Setting the Stage for Innovation at AHA 2024
We are thrilled to announce that Powerful Medical will be attending the American Heart Association (AHA) 2024 Conference, taking place from November 16th – 18th, 2024, at the McCormick Place Convention Center in Chicago, IL, USA.
We are set to make a significant impact with multiple sessions highlighting our cutting-edge innovations in AI-driven cardiovascular care. Our team, alongside experts from Mount Sinai and Washington University Hospital in St. Louis, will present research demonstrating how our technology enhances diagnostic accuracy, enables early diagnosis, and expedites treatment – offering a glimpse into the future of cardiovascular medicine.
Don’t Miss Our Sessions
On November 18th, Dr. Robert Herman from Powerful Medical will present Deep-learning Assisted ECG-based Emergent Cathlab Activation: First Prospective Implementation of a Smartphone-based System. This moderated digital poster session, part of the ‘’AI in ACS’’ track, will take place at 11:20 AM CST in Zone 4. Dr. Herman will highlight our innovative smartphone-based solution, designed to optimize emergency pathways for chest pain patients.
Advancing Equity in Cardiac Care
On November 16th, Dr. Timea Kisova will present her findings on Female Patients with Occlusive Myocardial Infarction without ST Elevation Experience Longer Delays in Receiving Emergent Reperfusion. Her moderated digital poster presentation is part of the “STEMI: Factors in Outcomes” session, scheduled to begin at 11:40 AM CST in Zone 4. The study highlights the gender disparities in the treatment of myocardial infarctions within the NSTEMI-OMI category, underscoring the urgent need for systemic changes to close these critical gaps, reinforcing our commitment to health equity in cardiac care.
Democratizing Diagnostics: AI Beyond Hospital Walls
Later on November 16th, at 1:10 PM CST, Dr. Anthony Demolder will share insights into our AI-Powered Smartphone Application for Detection of Left Ventricular Systolic Dysfunction using 12-Lead ECG. His moderated digital poster will be presented at Zone 3 in the session “Out of Office: Health Technology in the Community.” This presentation will highlight how our technology extends beyond hospital settings, making advanced diagnostics accessible in community and remote environments. By democratizing cardiac care and enhancing accessibility, we aim to bridge gaps in health equity and ensure that critical diagnostic tools are available to all, regardless of location or resources.
Independent External Validations of PMcardio
Real-World Evidence from Leading Institutions
We are proud to showcase independent validation studies of our AI tool, PMcardio (Queen of Hearts), conducted in partnership with our collaborating institutions. On November 18th, Dr. Samantha Harris from Washington University Hospital in St. Louis will present Artificial Intelligence Tool Accurately Predicts Occlusion Myocardial Infarction And May Reduce False-Positive Cath Lab Activations. This moderated digital poster session is part of the “AI in ACS” track and will be held from 11:50 AM CST in Zone 4. Her research demonstrates the efficacy of our AI system in accurately identifying myocardial infarction, potentially reducing unnecessary cath lab activations.
Following that, Dr. James Choi from Mount Sinai Morningside in New York will present a retrospective review titled AI-Enhanced Recognition of Occlusion in Acute Coronary Syndrome (AERO-ACS). His presentation, also in the “AI in ACS” session, will start at 12:00 PM CST at the same location. His work supports the capabilities of our AI tools in improving diagnostic accuracy and patient outcomes in acute coronary syndrome.
PMcardio Sessions at AHA 2024
| Title | Presenting Author | Session | Type of Presentation | Date & Time | Location |
|---|---|---|---|---|---|
| Female Patients with Occlusive Myocardial Infarction without ST Elevation Experience Longer Delays in Receiving Emergent Reperfusion | Dr. Timea Kisova | STEMI: Factors in Outcomes | Moderated Digital Poster Session | 16th November, 2024: 11:40 AM CST | Zone 4, Moderated Digital Poster 19, McCormick Place Convention Center |
| AI-Powered Smartphone Application for Detection of Left Ventricular Systolic Dysfunction using 12-Lead ECG | Dr. Anthony Demolder | Out of Office: Health Technology in the Community | Moderated Digital Poster Session | 16th November, 2024: 1:10 PM CST | Zone 3, Moderated Digital Poster 12, McCormick Place Convention Center |
| Deep-learning Assisted ECG-based Emergent Cathlab Activation: First Prospective Implementation of a Smartphone-based System | Dr. Robert Herman | AI in ACS | Moderated Digital Poster Session | 18th November, 2024: 11:20 AM CST | Zone 4, Moderated Digital Poster 19, McCormick Place Convention Center |
| Artificial Intelligence Tool Accurately Predicts Occlusion Myocardial Infarction And May Reduce False-Positive Cath Lab Activations | Dr. Samantha Harris, Washington University Hospital, St. Louis | AI in ACS | Moderated Digital Poster Session | 18th November, 2024: 11:50 AM CST | Zone 4, Moderated Digital Poster 19, McCormick Place Convention Center |
| AI-Enhanced Recognition of Occlusion in Acute Coronary Syndrome (AERO-ACS): A Retrospective Review | Dr. James Choi, Mount Sinai Morningside, New York | AI in ACS | Moderated Digital Poster Session | 18th November, 2024: 12:00 PM CST | Zone 4, Moderated Digital Poster 19, McCormick Place |
We invite all attendees to visit our sessions and learn more about how our technology is shaping the future of cardiac care. Let’s connect and explore innovative solutions that bring precision and efficiency to cardiovascular diagnostics.
We look forward to engaging with the cardiovascular community in person at AHA 2024 and discussing how our innovations are advancing cardiac care.
